Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
Source: Finance News Network
19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including its progress with manufacturing, securing patents and presenting to a global audience.
Read More03 May 2024 - US ban on Russian uranium imports could reshape the global market. Cauldron Energy's CEO Jonathan Fisher shares insights and implications for supply and prices.
Read More10 Jul 2023 - INOVIQ Limited (ASX:IIQ) CEO Dr Leearne Hinch discusses recent news, including excellent sensitivity and specificity results for the company's SubB2M breast cancer test.
Read More05 Dec 2019 - Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts talks about progress with the company's human assisted reproductive device for the separation of sperm cells in IVF clinics.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More14 Feb 2024 - Western Yilgarn Limited (ASX:WYX) General Manager Gavin Rutherford provides an introduction to the company, discussing its highly prospective nickle and platinum group elements tenements in Western Australia.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More06 Mar 2024 - Arrow Minerals (ASX:AMD) Managing Director David Flanagan provides introduction to the company, discussing the companies Simandou North Iron Project in West Africa.
Read More17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
Read More28 Sep 2022 - Meeka Metals Limited (ASX:MEK) Managing Director and CEO Tim Davidson discusses recent gold and rare earths results and the outlook for the next year.
Read More
